This study is currently not recruiting participants.

An Open-Label Long Term Safety Study of SD-809 ER in Subjects with Chorea Associated with Huntington Disease (ARC-HD)

Investigation of an Investigational Medication for Chorea (a movement disorder causing involuntary, irregular movements) in Huntington's Disease

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

This study will look at what the body does to the study drug and if the drug lessens chorea in Huntington's Disease.

Detailed description of study

This study will look at what the body does to the study drug and if the drug lessens chorea in Huntington's Disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Huntington Disease,Chorea
  • Age: 18 years - 100 years
  • Gender: All

This study investigates the effects of an investigational medication on chorea associated with Huntington's Disease. Chorea is a movement disorder that causes involuntary, irregular movements. The purpose of this study is to understand how the body processes the investigational medication and to evaluate its impact on reducing chorea symptoms.

Participants in the study will be given the investigational medication, and researchers will monitor its effects on chorea. The study will involve assessing how the medication is absorbed, distributed, and eliminated by the body. This information will help determine the medication's potential effectiveness in managing chorea symptoms.

  • Who can participate: Details about who can participate in the study are not provided.
  • Study details: Participants will take the investigational medication, and researchers will observe its effects on chorea symptoms.
Updated on 19 Feb 2024. Study ID: 1405196617

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team